September 29, 2021 - Today during alive programfeaturing industry leaders, Johnson & Johnson Innovation LLC, together with Janssen Research & Development LLC, launched theImmunology Innovations QuickFire Challenge.Innovators from across the global are invited to submit transformative potential solutions aiming to advance precision medicine approaches in immune-mediated diseases. Specific disease areas of focus for this challenge include gastroenterology, rheumatology, dermatology, fetal-maternal diseases, autoantibody-mediated diseases, and other immune-mediated diseases areas where a stratified approach has the potential to be transformational for patients.
Of the 30 million patients diagnosed with moderate-to-severe forms of chronic immune diseases, only 5 million receive advanced therapies and only 2 million experience adequate responses. A key barrier to the development of novel therapies and treatment paradigms has been the complexity and heterogeneity of these diseases, which consist of different disease states with distinct unmet medical need and biology.
By harnessing scientific advances in understanding of disease pathophysiology in different tissues and organs and identifying biomarkers for mechanistic stratification, we can potentially develop new medicines with mechanisms of action tailored to differentiated patient populations.
The innovator(s) with the best idea, therapy or technology, or novel approach will receive grant funding from a total of up to $500,000; access to the global JLABS network including the potential to be considered for future opportunities like research collaborations, NewCos, etc.; and mentorship from experts across the Johnson & Johnson Family of Companies.
Apply athttp://jji.jnj/immunology2022年1月14日。
The QuickFire Challenges are managed by Johnson & Johnson Innovation, with the goal to help address today’s greatest health care challenges.
About Johnson & Johnson Innovation LLC
ld乐动强生公司创新有限责任公司在工作pharmaceutical, medical device and consumer health sectors to accelerate early-stage, transformational solutions by catalyzing the best ideas, wherever they are in the world. We do this by harnessing our deep scientific capabilities coupled with a wide range of tools, including customized deal structures, company creation, incubation and startup services, capital investments and other innovative business models that aim to meet the diverse needs of entrepreneurs, scientists and emerging companies. Our goal is to help life science and health technology innovations thrive through collaboration and partnership with the global ecosystem, so that together we can change the trajectory of human health. Meet our passionate team of science and technology experts and learn how to collaborate with us at www.jnjinnovation.com.
About Janssen Research & Development LLC
At Janssen, we’re creating a future where disease is a thing of the past. We’re the Pharmaceutical Companies of Johnson & Johnson, working tirelessly to make that future a reality for patients everywhere by fighting sickness with science, improving access with ingenuity, and healing hopelessness with heart. We focus on areas of medicine where we can make the biggest difference: Cardiovascular & Metabolism, Immunology, Infectious Diseases & Vaccines, Neuroscience, Oncology, and Pulmonary Hypertension.
